|
1
|
Xiao JX, Xu W, Fei X, Hao F, Wang N, Chen
Y and Wang J: Anillin facilitates cell proliferation and induces
tumor growth of hepatocellular carcinoma via miR-138/SOX4 axis
regulation. Transl Oncol. 13(100815)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Vilgrain V, Pereira H, Assenat E, Guiu B,
Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W,
et al: Efficacy and safety of selective internal radiotherapy with
yttrium-90 resin microspheres compared with sorafenib in locally
advanced and inoperable hepatocellular carcinoma (SARAH): An
open-label randomised controlled phase 3 trial. Lancet Oncol.
18:1624–1636. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Coskun M: Hepatocellular carcinoma in the
cirrhotic liver: Evaluation using computed tomography and magnetic
resonance imaging. Exp Clin Transplant. 15 (Suppl 2):S36–S44.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Granito A and Bolondi L: Non-transplant
therapies for patients with hepatocellular carcinoma and
Child-Pugh-Turcotte class B cirrhosis. Lancet Oncol. 18:e101–e112.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ghouri YA, Mian I and Rowe JH: Review of
hepatocellular carcinoma: Epidemiology, etiology, and
carcinogenesis. J Carcinog. 16(1)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mahtab MA, Chaudhury M, Uddin MH, Noor
EASM, Rahim MA, Alam MA, Moben AL, Khondaker FA, Choudhury MF,
Sarkar MJ, et al: Cost assessment of Hepatitis B virus-related
hepatitis in Bangladesh. Euroasian J Hepatogastroenterol.
6:163–166. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sarma MP, Bhattacharjee M, Kar P and Medhi
S: Detection of HBV genotype C in hepatocellular carcinoma patients
from north east India: A brief report. Asian Pac J Cancer Prev.
19:1741–1746. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Reig M, Mariño Z, Perelló C, Iñarrairaegui
M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, et al:
Unexpected high rate of early tumor recurrence in patients with
HCV-related HCC undergoing interferon-free therapy. J Hepatol.
65:719–726. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dituri F, Mancarella S, Cigliano A, Chieti
A and Giannelli G: TGF-β as multifaceted orchestrator in HCC
progression: Signaling, EMT, immune microenvironment, and novel
therapeutic perspectives. Semin Liver Dis. 39:53–69.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Artero-Castro A, Kondoh H,
Fernandez-Marcos PJ, Serrano M, Ramon y Cajal S and Lleonart ME:
Rplp1 bypasses replicative senescence and contributes to
transformation. Exp Cell Res. 315:1372–1383. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Artero-Castro A, Perez-Alea M, Feliciano
A, Leal JA, Genestar M, Castellvi J, Peg V, Ramon y Cajal S and
Lleonart ME: Disruption of the ribosomal P complex leads to
stress-induced autophagy. Autophagy. 11:1499–1519. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Campos RK, Wong B, Xie X, Lu YF, Shi PY,
Pompon J, Garcia-Blanco MA and Bradrick SS: RPLP1 and RPLP2 are
essential flavivirus host factors that promote early viral protein
accumulation. J Virol. 91(e01706)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
He Z, Xu Q, Wang X, Wang J, Mu X, Cai Y,
Qian Y, Shao W and Shao Z: RPLP1 promotes tumor metastasis and is
associated with a poor prognosis in triple-negative breast cancer
patients. Cancer Cell Int. 18(170)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Artero-Castro A, Castellvi J, Garcia A,
Hernandez J, Ramon y Cajal S and Lleonart ME: Expression of the
ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors.
Hum Pathol. 42:194–203. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Roels S, Tilmant K and Ducatelle R: PCNA
and Ki67 proliferation markers as criteria for prediction of
clinical behaviour of melanocytic tumours in cats and dogs. J Comp
Pathol. 121:13–24. 1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang H, Wang Y and Ding H: COL4A1,
negatively regulated by XPD and miR-29a-3p, promotes cell
proliferation, migration, invasion and epithelial-mesenchymal
transition in liver cancer cells. Clin Transl Oncol: Apr 23, 2021
(Epub ahead of print).
|
|
19
|
Beudeker BJB and Boonstra A: Circulating
biomarkers for early detection of hepatocellular carcinoma. Therap
Adv Gastroenterol. 13(1756284820931734)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 16:589–604. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Leiphrakpam PD, Lazenby AJ, Chowdhury S,
Smith LM, Mathiesen M, Brattain MG, Wang J, Black JD and Are C:
Prognostic and therapeutic implications of NHERF1 expression and
regulation in colorectal cancer. J Surg Oncol. 121:545–560.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang XJ, Yu Q, Chi P, Lin HM, Lu XR, Huang
Y, Xu ZB, Huang SH, Sun YW and Ye DX: Identification of gene
biomarkers to predict responses to neoadjuvant chemoradiotherapy in
patients with rectal cancer and pathways enrichment analysis.
Zhonghua Wei Chang Wai Ke Za Zhi. 22:1183–1187. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
23
|
Liu YP, Chen WD, Li WN and Zhang M:
Overexpression of FNDC1 relates to poor prognosis and its knockdown
impairs cell invasion and migration in gastric cancer. Technol
Cancer Res Treat. 18(1533033819869928)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu ZH, Wang YM, Jiang YZ, Ma SJ, Zhong Q,
Wan YY and Wang XW: NID2 can serve as a potential prognosis
prediction biomarker and promotes the invasion and migration of
gastric cancer. Pathol Res Pract. 215(152553)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xia L, Yue Y, Li M, Zhang YN, Zhao L, Lu
W, Wang X and Xie X: CNN3 acts as a potential oncogene in cervical
cancer by affecting RPLP1 mRNA expression. Sci Rep.
10(2427)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang G and Zhang G: Upregulation of FoxP4
in HCC promotes migration and invasion through regulation of EMT.
Oncol Lett. 17:3944–3951. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Juríková M, Danihel Ľ, Polák S and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Serrano-Gomez SJ, Maziveyi M and Alahari
SK: Regulation of epithelial-mesenchymal transition through
epigenetic and post-translational modifications. Mol Cancer.
15(18)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tafrihi M and Nakhaei Sistani R:
E-Cadherin/β-catenin complex: A target for anticancer and
antimetastasis plants/plant-derived compounds. Nutr Cancer.
69:702–722. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bjorklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI View Article : Google Scholar
|
